Li Y - Search Results

1

Predicting the nature of pleural effusion in patients with lung adenocarcinoma based on ¹⁸F-FDG PET/CT.

Li Y, Mu W, Li Y, Song X, Huang Y, Jiang L. Li Y, et al. EJNMMI Res. 2021 Oct 15;11(1):108. doi: 10.1186/s13550-021-00850-2. EJNMMI Res. 2021. PMID: 34652524 Free PMC article.

2

A Case of Mediastinal Leiomyosarcoma Demonstrated on FDG PET/CT Imaging.

Wu X, Huang Y, Li Y, Wang H, Jiang L. Wu X, et al. Among authors: li y. Clin Nucl Med. 2019 Mar;44(3):e158-e160. doi: 10.1097/RLU.0000000000002436. Clin Nucl Med. 2019. PMID: 30624267

3

Detecting Vulnerable Atherosclerotic Plaques by ⁶⁸Ga-Labeled Divalent Cystine Knot Peptide.

Jiang L, Zhu H, Li Y, Wu X, Wang H, Cheng Z. Jiang L, et al. Among authors: li y. Mol Pharm. 2019 Mar 4;16(3):1350-1357. doi: 10.1021/acs.molpharmaceut.8b01291. Epub 2019 Feb 20. Mol Pharm. 2019. PMID: 30742442

4

Dual-modality imaging of atherosclerotic plaques using ultrasmall superparamagnetic iron oxide labeled with rhodamine.

Li Y, Pan Y, Wu X, Li Y, Wang H, Zhu H, Jiang L. Li Y, et al. Nanomedicine (Lond). 2019 Aug;14(15):1935-1944. doi: 10.2217/nnm-2019-0062. Epub 2019 Jul 29. Nanomedicine (Lond). 2019. PMID: 31355711

5

PD-L1 expression correlation with metabolic parameters of FDG PET/CT and clinicopathological characteristics in non-small cell lung cancer.

Wu X, Huang Y, Zhao Q, Wang L, Song X, Li Y, Jiang L. Wu X, et al. Among authors: li y. EJNMMI Res. 2020 May 19;10(1):51. doi: 10.1186/s13550-020-00639-9. EJNMMI Res. 2020. PMID: 32430866 Free PMC article.

6

Usefulness of ¹⁸F-FDG PET/CT in treatment-naive patients with thymic squamous cell carcinoma.

Li Y, Li Y, Huang Y, Wu X, Yang Z, Wu C, Jiang L. Li Y, et al. Ann Nucl Med. 2021 Sep;35(9):1048-1057. doi: 10.1007/s12149-021-01640-5. Epub 2021 Jun 8. Ann Nucl Med. 2021. PMID: 34101153

7

The significant value of predicting prognosis in patients with colorectal cancer using ¹⁸F-FDG PET metabolic parameters of primary tumors and hematological parameters.

Xu J, Li Y, Hu S, Lu L, Gao Z, Yuan H. Xu J, et al. Among authors: li y. Ann Nucl Med. 2019 Jan;33(1):32-38. doi: 10.1007/s12149-018-1299-z. Epub 2018 Sep 14. Ann Nucl Med. 2019. PMID: 30218280

8

Prognostic Value of Tumor Heterogeneity on 18F-FDG PET/CT in HR+HER2- Metastatic Breast Cancer Patients receiving 500 mg Fulvestrant: a retrospective study.

Zhao Y, Liu C, Zhang Y, Gong C, Li Y, Xie Y, Wu B, Yang Z, Wang B. Zhao Y, et al. Among authors: li y. Sci Rep. 2018 Sep 27;8(1):14458. doi: 10.1038/s41598-018-32745-z. Sci Rep. 2018. PMID: 30262849 Free PMC article. Clinical Trial.

9

Heterogeneity of targeted lung lesion predicts platinum-based first-line therapy outcomes and overall survival for metastatic triple-negative breast cancer patients with lung metastasis: a "PET biopsy" method.

Xie Y, Gu B, Hu X, Zhang Y, Zhang J, Wang Z, Zhao Y, Gong C, Li Y, Yang Z, Wang B. Xie Y, et al. Among authors: li y. Cancer Manag Res. 2019 Jul 2;11:6019-6027. doi: 10.2147/CMAR.S204364. eCollection 2019. Cancer Manag Res. 2019. PMID: 31308743 Free PMC article.

10

Prediction of Pretreatment 18F-FDG-PET/CT Parameters on the Outcome of First-Line Therapy in Patients with Metastatic Breast Cancer.

Li Y, Liu C, Wang B, Hu X, Gong C, Zhao Y, Xie Y, Zhang Y, Song S, Yang Z, Wang B. Li Y, et al. Int J Gen Med. 2021 May 11;14:1797-1809. doi: 10.2147/IJGM.S293998. eCollection 2021. Int J Gen Med. 2021. PMID: 34007206 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

239,133 results

Search Page

Filters